[quote KeepOnKeepingOnAgainandAgain]@Imaginetoday - forgive me for questioning you but what is the difference between this vaccine - with no data to support impact on transmission or data to support length of effectivity (on severity of illness) and other vaccines - say measles?
Do other vaccines mean that you still be infected and infectious but less likely to suffer severe illness? I thought vaccines meant you didn't become infected. Data exists with older vaccines - even if we are ignorant of it - but not so much with novel vaccines.
Is there even RCT that show that people who have been immunised with novel vaccines have less severe illness, shorter hospital stays, lower mortality compared to those who have not been immunised?
Is a theoretical reduction of transmission based solely on less severe illness so less viral load?
Why aren't other prophylactic treatments used where evidence exists?
Are people with greater transmission risks (working outside the home, younger, public facing etc) not being vaccinated because impact on transition is unknown?
I can understand frustration and confusion and the desire for absolutes. Trying to deal with scientific uncertainties and match this to political optimistic truths is a hard place to be. [/quote]
Hey, great questions but out of my realms of knowledge. We need a virologist to answer! My experience was in production.
My guess answer based on my limited knowledge of how vaccines work and different types that there are lots of different vaccine mechanisms. So vaccines are packets of DNA. They need a host cell to infect to replicate. Vs bacteria that can divide and replicate themselves.
Different vaccines are made with live virus , or deactivated virus, and some are made by fragmenting the virus. What scientists are looking for is the parts of the virus that trigger the immune response. So even with covid all the vaccines are taking different approaches to produce that immune response including some very novel approaches relating to replication of DNA.
So, my assumption has always been that different vaccines, depending on what and how they trigger the immune, will have better effectivity in preventing symptoms and different efficacy in preventing transmission.
The more novel the approach the less data we have at long term data such as transmission and how long immunity last for.
Any virologist out there care to correct me or explain more?